Navigation Links
ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR

uct candidates will be successful, or such product candidates will be successfully commercialized. Other risks that affect forward-looking information contained in this press release include the possibility of being unable to obtain regulatory approval of the Company's product candidates, the risk that the results of clinical trials may not support the Company's claims, and risks related to the Company's ability to protect its intellectual property and its reliance on third parties to develop its product candidates. The Company assumes no obligation to update these forward-looking statements, except as required by law.

ZIOP-G

Contact

ZIOPHARM Oncology, Inc.
Investors
Suzanne McKenna, 646-214-0703
smckenna@ziopharm.com
or
Media
Tina Posterli, 917-322-2565
tposterli@rxir.com


'"/>




Page: 1 2 3

Related medicine technology :

1. ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR
3. ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR
4. ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
7. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
8. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
9. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ZIOPHARM Presents Data Highlighting Oral ZIO AACR
(Date:5/20/2008)...e-FirstCall/ -- An interim analysis of a,study pre...Week (DDW),Conference found that, among patients a...ed an annual fecal immunochemical (FIT) test, dete...26.5 months earlier than would,have occurred durin...py.,Detection of precancerous lesions in this grou...
(Date:5/20/2008)...FirstCall/ -- Omeros Corporation today,announced t...1 study of,OMS201, the Company,s second PharmacoSu...rological surgery. At least 24 patients undergoing... maximum diameter of 12 mm,located in the renal-co...study., "Advancing another PharmacoSurgery(TM) pr...
(Date:5/20/2008)...romist(TM) (Formoterol Fumarate) Inhalation ...ce --, NAPA, Calif., May 20 /- Data ... the American Thoracic Society (ATS) demonstrate,t...ation Solution,(formoterol fumarate inhalation sol...va(R) (tiotropium; TIO) is significantly more effe...
(Date:5/20/2008)...nternational Conference of the American ...0 /- Forest Laboratories, I...d results from four clinical,trials assessing the ...stigational treatment for chronic obstructive pulm...tudies further describing the properties of,aclidi...
Breaking Medicine Technology:Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 2Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 3Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 4Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 5Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study 2Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 2Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 3Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 4Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 5Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 6Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 2Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 3Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 4Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 5Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile 321 1Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile 321 2Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile 321 3Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile 321 4Pregnancy may slow not accelerate progression to AIDS 1581 1Pregnancy may slow not accelerate progression to AIDS 1581 2Pregnancy may slow not accelerate progression to AIDS 1581 3Why are some groups of animals so diverse 3F 1579 1Why are some groups of animals so diverse 3F 1579 2Canadas pristine freshwater fisheries at risk 457 1Canadas pristine freshwater fisheries at risk 457 2Canadas pristine freshwater fisheries at risk 457 3
...007 /PRNewswire/ -- Alfacell,Corporation today ann...sident, chief financial officer and corporate secr...roduct development programs,at 8 a.m. EDT on Thurs...Emerging Growth Opportunities Conference in New Yo...ilable live at,<a target="_blank" href=,"http://ww...
...UNSWICK, New Jersey, July 03, 2007,/PRNewswire-Fir...NA,company, announced today that J. Michael French...nterberg, Towbin Emerging Growth,Opportunities Con...e Mandarin Oriental Hotel in New York. , A live au...on,the "Investors" section of the company,s websit...
Other Medicine Technology:Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging,Growth Opportunities Conference 2Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference 2
(Date:5/20/2008)...Ambulatory Services of,America, Inc. announced the...t venture to provide outpatient radiation oncology...en Denton Cancer Center, LP and ASA,s,subsidiary, ...of Denton,will own and operate a radiation therapy...ed and operated by Denton Cancer Center., (Logo: ...
(Date:5/20/2008)... out-patient procedures at no c...., May 20 /PRNewswire/ -- Compass Clinical Researc...rancisco Bay Area (RSC) are,hoping to recruit betw...build-up of fluid in the fallopian tubes that can ...part of a study of the effectiveness of a new,out-...
(Date:5/20/2008)...d Fat - and with Omega-3, PARAMUS, N.J., May 20 /...q: SMBL ) has launched Smart Balance(R) Butter Bl...Blend Sticks are 50 percent real butter,and 50 per...lance(R) Butter,Blend Sticks are offered in a conv...ealthier and tasty alternative for use in cooking,...
(Date:5/20/2008)... survival, researchers say. , , TUESDAY...ysis for patients with acute kidney injury does no... the rate of organ failure, a new study finds. ,... in critically ill patients. Approximately 2 perce...ercent of critically ill patients, will suffer fro...
Breaking Medicine News(10 mins):Health News:Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP 2Health News:Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes 2Health News:Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes 3Health News:New Smart Balance(R) Butter Blend Sticks Make Healthier Cooking & Baking Easy 2Health News:More Dialysis Not Better in Acute Kidney Injury 2
...ntists have identified a protein in the brain of r...y haven't yet tested how the protein behaves in hu...es at the Institute of Neuroscience of the Consigl... Research Council) in Rome spotted the TLQP-21 pro...
...AGO - Patients with allergic rhinitis, such as tha...re difficulty sleeping and more sleep disorders// ...t in the September 18 issue of Archives of Interna...llergic rhinitis, which occurs when pollen or othe...
... the expansion of the NHS ?12 billion computer sys... 110 "major incidents" in four months//. These pro...X-rays on screens in operating theatres. Details o...ve also been left inaccessible on several occasion...
...cent report by the Ministry in Jamaica has reveale...n Jamaica, in a paper that has now come before the...ple infected with the HIV virus live healthy lives...loping the full-blown disease, many others don't. ...
Other Medicine News:Health News:Allergic Rhinitis Associated with Impaired Sleep Quality 2Health News:NHS Inconvenienced by 110 major computer failures 2
...ists steerable guidewires across difficult lesions...eter offers a low profile (3F-4F) and is compatibl... crossing difficult occlusions. Once the occlusio...guidewire position and an angioplasty balloon is d...
Introduced more than 30 years ago by Dr. Thomas J. Fogarty, these embolectomy catheters are indicated for the removal of fresh, soft emboli and thrombi from vessels in the arterial system.
The new XVG catheter is our highest power thrombectomy catheter designed for accessing distal anatomy. Utilizing proprietary Cross-Stream water jet technology, the XVG catheter removes thrombus quick
...copic navigation system that tracks multiple intra...d Wittkampf, Ph.D., and is being developed by Surg...,The LocaLisa system uses three skin electrode p...art to track catheters. Using a reference electrod...
Medicine Products: